The Allurion Programme combines the Allurion Gastric Balloon, expert medical guidance, personalised nutrition coaching and a powerful suite of digital tools to deliver fast, healthy and sustainable weight loss
doi: 10.20945/2359-3997000000191
Zepbound KwikPen is the newest FDA-approved weight loss injection in a convenient pre-filled pen format, featuring a dual-action formula that activates both GIP and GLP-1 receptors
Below is a summary of clinical outcomes associated with some commonly prescribed GLP-1 medications: In a 68-week trial, participants receiving semaglutide experienced an average weight reduction of approximately 14.9%, compared to 2.4% in the placebo group
In the U.S., post-market surveillance from 2005 to 2023 recorded more than 6,700 cases of pancreatitis tied to GLP-1 medications, contributing to rising concern among medical professionals and Ozempic lawyers
Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B1
